124 related articles for article (PubMed ID: 21929507)
1. Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmission.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Biochem J; 2012 Jan; 441(1):443-52. PubMed ID: 21929507
[TBL] [Abstract][Full Text] [Related]
2. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
Lawrence GW; Wang J; Brin MF; Aoki KR; Wheeler L; Dolly JO
FEBS J; 2014 Jul; 281(14):3243-60. PubMed ID: 24863955
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
4. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
5. Structural and Functional Interactions between Transient Receptor Potential Vanilloid Subfamily 1 and Botulinum Neurotoxin Serotype A.
Li X; Coffield JA
PLoS One; 2016; 11(1):e0143024. PubMed ID: 26745805
[TBL] [Abstract][Full Text] [Related]
6. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells.
da Silva LB; Poulsen JN; Arendt-Nielsen L; Gazerani P
J Cell Mol Med; 2015 Aug; 19(8):1900-9. PubMed ID: 25754332
[TBL] [Abstract][Full Text] [Related]
8. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
10. Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a.
Wang T; Martin S; Papadopulos A; Harper CB; Mavlyutov TA; Niranjan D; Glass NR; Cooper-White JJ; Sibarita JB; Choquet D; Davletov B; Meunier FA
J Neurosci; 2015 Apr; 35(15):6179-94. PubMed ID: 25878289
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.
Restani L; Novelli E; Bottari D; Leone P; Barone I; Galli-Resta L; Strettoi E; Caleo M
Traffic; 2012 Aug; 13(8):1083-9. PubMed ID: 22519601
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxins: mechanism of action.
Tighe AP; Schiavo G
Toxicon; 2013 Jun; 67():87-93. PubMed ID: 23201505
[TBL] [Abstract][Full Text] [Related]
13. Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis.
Wang J; Zurawski TH; Meng J; Lawrence GW; Aoki KR; Wheeler L; Dolly JO
FASEB J; 2012 Dec; 26(12):5035-48. PubMed ID: 22942075
[TBL] [Abstract][Full Text] [Related]
14. Long-distance retrograde effects of botulinum neurotoxin A.
Antonucci F; Rossi C; Gianfranceschi L; Rossetto O; Caleo M
J Neurosci; 2008 Apr; 28(14):3689-96. PubMed ID: 18385327
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
Dolly JO; Wang J; Zurawski TH; Meng J
FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
[TBL] [Abstract][Full Text] [Related]
16. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons.
Morris JL; Jobling P; Gibbins IL
Am J Physiol Heart Circ Physiol; 2001 Nov; 281(5):H2124-32. PubMed ID: 11668074
[TBL] [Abstract][Full Text] [Related]
18. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
[TBL] [Abstract][Full Text] [Related]
19. Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder.
Coelho A; Dinis P; Pinto R; Gorgal T; Silva C; Silva A; Silva J; Cruz CD; Cruz F; Avelino A
Eur Urol; 2010 May; 57(5):884-90. PubMed ID: 20044204
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin type A: Actions beyond SNAP-25?
Matak I; Lacković Z
Toxicology; 2015 Sep; 335():79-84. PubMed ID: 26169827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
